Nurix Therapeutics shows strong BTK degrader data and key pharma ties, with risks but solid long-term potential. Find out why ...

Arvinas PROTAC protein degraders have some potential, with vepdegestrant as its late-stage, most promising asset, partnered ...

Micron Technology, Inc. (NASDAQ:MU) is one of the best large-cap stocks to buy right now. On June 26, Baird increased its ...